MindWalk + Vultr: Accelerating AI-Driven Drug Discovery
MindWalk + Vultr: Accelerating AI-Driven Drug Discovery
Vultr's cloud GPU offerings and flexible compute options enabled 50-66% cost savings and improved AI scalability for MindWalk.
Vultr's cloud GPU offerings and flexible compute options enabled 50-66% cost savings and improved AI scalability for MindWalk.
MindWalk needed a cloud provider to scale complex AI workloads for therapeutic antibody discovery. They required a solution that balanced performance with cost efficiency, while adhering to strict GDPR and other compliance standards.
MindWalk selected Vultr for its high-performance cloud GPU offerings, managed Kubernetes, and automated provisioning. This enabled agile development, reduced costs significantly, and ensured compliance for mission-critical applications.
The strategic imperative: High-performance, compliant cloud for AI at scale
The strategic imperative: High-performance, compliant cloud for AI at scale
Life sciences companies need cloud providers that deliver technical advantages and commercial flexibility. Vultr's cloud GPU offerings, coupled with Terraform integration, provide the performance, scalability, and cost efficiency needed for AI-driven drug discovery. Transparent billing and GDPR-compliant regions offer further trust in Vultr's solutions for mission-critical applications.
Get started with
world’s largest privately-held cloud
infrastructure company
Create an accountGet started with
world’s largest privately-held cloud
infrastructure company